ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Clinical trials for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for obese women with endometrial cancer: Weight-Based drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests the safety of combining two drugs, atezolizumab and ONC201, in 58 women with advanced or recurrent endometrial cancer. The study compares how obese and non-obese patients respond to the treatment. The goal is to find the best dose and see if the combi…
Matched conditions: ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 01:51 UTC
-
Shorter radiation may ease burden for early endometrial cancer patients
Symptom relief Recruiting nowThis study compares a shorter course of internal radiation (vaginal cuff brachytherapy) to the standard longer course for people with stage I-II endometrial cancer. The goal is to see if the shorter treatment improves quality of life and reduces financial burden. About 188 partic…
Matched conditions: ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE3 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Apr 29, 2026 01:51 UTC